Kir3dl2 Is Expressed in Peripheral T-Cell Lymphomas and May Be a Therapeutic Target

Hematological Oncology - United Kingdom
doi 10.1002/hon.21_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Guest Editorial: Peripheral T-Cell Lymphomas: Progress Is Not “Peripheral”, but “Central”

International Journal of Hematology
Hematology
2014English

Membrane Expression of Nk Receptor Kir3dl2 Contributes to Delineate the Acute-Type and Is a Therapeutic Target in Adult T-Cell Leukemia/Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Cyclin D1 Expression in Peripheral T-Cell Lymphomas

Modern Pathology
Forensic MedicinePathology
2016English

The Aggressive Peripheral T-Cell Lymphomas: 2017

American Journal of Hematology
Hematology
2017English

Pre-T Cell Receptor Signaling Drives Leukemogenesis and Is a Therapeutic Target in T Cell Acute Lymphoblastic Leukemia

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Therapeutic Options in Peripheral T Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Tanslocations Involving Cd28 Are Rare in Peripheral T-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Overexpression of Syk Tyrosine Kinase in Peripheral T-Cell Lymphomas

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Survivin Is a Therapeutic Target in Merkel Cell Carcinoma

Science Translational Medicine
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy